Category Archives: Product Recalls

Nationwide Recall of Anticoagulant, Dabigatran Etexilate (generic substitute for Pradaxa)

A voluntary recall has been issued by Ascend Laboratories, LLC for specific lots of Dabigatran Etexilate Capsules (a generic substitute for Pradaxa) due to detection of an impurity within the medication. It has been found that a dangerous level of a nitrosamine called N-nitroso-dabigatran, a substance known to cause cancer is present in the drug. At the time of the writing of this notice, no adverse reactions have been reported but patients are being cautioned to follow proper procedures if their stock of medication is affected.

SUMMARY

Date of Recall:

Announced: March 22, 2023

Public Notification: March 22, 2023

Name(s) of Drug:

Dabigatran Etexilate

Company Name:

Ascend Laboratories, LLC

Drug Indication:

Atrial Fibrillation

Deep Vein Thrombosis (DTV)

Pulmonary Embolism (PE)

Prevention of Blood Clots in those who present a high risk

 

Product Description

The drug is distributed by licensed pharmacies in white, plastic bottles. Information regarding lot number, NDC number, expiration date and count-per-bottle can be located on the label. All affected lots are contained within the 75mg and 150mg capsule distributions.

Reason for Recall

The particular lots involved in the recall have been found to contain a dangerously high level of the nitrosamine, N-nitroso-dabigatran, a substance that has been found to increase the risk of cancer. While the nitrosamine is not dangerous in small doses, continued exposure is not recommended.

Impacts

Consumers may not experience any noticeable symptoms if their medication is affected. However, it is important to participate in the recall if your drug is listed as continued use can increase the risk of cancer.

Lot information

Consumers should locate the bottle in which the medication comes to compare NDC and lot numbers as well as expiration dates with the chart below. If you find your NDC number, lot number and expiration date on the chart below, your medication is affected by the recall and you will need to take additional steps in order to take part in recall procedures and ensure that your health is not affected.

Product NDC Lot
Number
Expiration
Date
Presentation Configuration
/Count
Dabigatran Etexilate
Mesylate Caps 150
Mg
67877-475-60 22142448 MAY.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 150
Mg
67877-475-60 22142449 MAY.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 150
Mg
67877-475-60 22142450 MAY.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 75 Mg
67877-474-60 22142462 MAY.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 75 Mg
67877-474-60 22142463 MAY.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 75 Mg
67877-474-60 22142464 MAY.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 75 Mg
67877-474-60 22143000 JUN.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 75 Mg
67877-474-60 22143001 JUN.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 75 Mg
67877-474-60 22143002 JUN.2024 HDPE
Bottles
60
capsules/bottle
Dabigatran Etexilate
Mesylate Caps 150
Mg
67877-475-60 22143845 JUL.2024 HDPE
Bottles
60
capsules/bottle

FDA.gov

Have you found that your medication is part of the recall? Here’s what you should do:

Consumers

NOTE: CONSUMERS SHOULD NOT DISCONTINUE THIS MEDICATION ABRUPTLY. SPEAK TO YOUR DOCTOR BEFORE MAKING ANY CHANGES.

DO NOT DISCONTINUE USE UNTIL ADVISED BY YOUR PHYSICIAN TO DO SO.

Discontinuation of this medication may put you at risk for clotting due to underlying conditions.

If you find that your lot of medication is part of this recall, do the following:

  1. Call your doctor right away. Ask for a new prescription to replace your recalled medication.
  2. Consumers may contact Ascend Laboratories, LLC at 1-877-272-7901. They are available 24/7.
  3. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Retailer

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact Ascend Laboratories, LLC at 1-877-272-7901. They are available 24/7. Notify them of any recalled batches that have already been sold to consumers.
  3. Notify affected consumers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Wholesaler

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact Ascend Laboratories, LLC at 1-877-272-7901. They are available 24/7. Notify them of any recalled batches that have already been shipped to retailers.
  3. Notify affected retailers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

 

 

Gerber Good Start SootheProTM Powdered Infant Formula, RECALLED!

A voluntary recall has been issued by Perrigo for limited quantities of their Gerber Good Start SoothePro TM Powdered Infant Formula due to possible presence of Cronobacter Sakazakii bacteria which can lead to fever, poor feeding, excessive crying or low energy in infants who are exposed. At this time of this notice, no adverse events have been reported and no formula has tested positive for the bacteria, but out of an abundance of caution, the company has chosen to move forward with the recall.

SUMMARY

Date of Recall:

Announced: March 17, 2023

Public Notification: March 17, 2023

Name(s) of Product:

Gerber Good Start SoothePro TM Powdered Infant Formula

Company Name:

Perrigo

Indication:

Infant feeding

Product Description

Product is distributed in cans in 12.4oz, 30.6oz and 19.4oz sizes with a blue lid and Gerber logo on the front.

Reason for Recall

There is reason to suspect that the formula processed in a Wisconsin manufacturing plant may have been exposed to the Cronobacter Sakazakii bacteria. While the bacteria does not cause any symptoms in healthy adults, it can be problematic for infants, especially those who are premature or immunocompromised.

Impacts

Infants fed the formula may experience fever, poor feeding, excessive crying or low energy as a result of exposure to the bacteria.

Lot information

Consumers should locate their can of formula and check for “use by” dates as well as lot codes located on the bottom of the package. Only the following listed lots and use by dates are affected:

Gerber® Good Start® SootheProTM 12.4 oz:
300357651Z – USE BY 04JUL2024
300457651Z – USE BY 05JUL2024
300557651Z – USE BY 06JUL2024
300557652Z – USE BY 06JUL2024
300757651Z – USE BY 08JUL2024
300857651Z – USE BY 09JUL2024
301057651Z – USE BY 11JUL2024
301057652Z – USE BY 11JUL2024
301157651Z – USE BY 12JUL2024

Gerber® Good Start® SootheProTM 30.6 oz:
301357652Z – USE BY 14JUL2024
301457652Z – USE BY 15JUL2024
301557651Z – USE BY 16JUL2024

Gerber Good® Start® SootheProTM 19.4 oz:
301557652Z – USE BY 16JUL2024I

Fda.gov

Have you found that your formula is part of the recall? Here’s what you should do:

Consumers

If you find that your lot of formula is part of this recall, do the following:

  1. Stop feeding your child this formula immediately and replace with a formula that is not part of the recall (note that this recall applies to only a small number of lots and expiration dates).
  2. Continue to monitor your baby’s health for any adverse symptoms over the next week and notify their physician if any concerns are noted.
  3. Consumers should contact the Gerber Parent Resource Center at 1-800-777-7690 for a refund. They are available 24/7.
  4. If your child is currently experiencing or has experienced an adverse reaction to this formula (listed above), notify your child’s physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled formula.

Retailer

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact Gerber Parent Resource Center at 1-800-777-7690. They are available 24/7. Notify them of any recalled batches that have already been sold to consumers.
  3. Notify affected consumers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled formula.

Wholesaler

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact Gerber Parent Resource Center at 1-800-777-7690. They are available 24/7.
  3. Notify them of any recalled batches that have already been shipped to retailers.
  4. Notify affected retailers of recalled batches that they have already or will receive.
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled formula.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

 

 

Check Your Pet’s Health Supplements! Major Recall Enacted!

Stratford Care USA, Inc has issued an immediate recall of their Omega-3 Supplements for cats and dogs after receiving a report of a dog exhibiting signs of Vitamin A toxicity. The product is sold under various names and through channels such as veterinary clinics as well as online and in-person retailers including Amazon and Chewy.

SUMMARY

Date of Recall:

Announced: March 9, 2023

Public Notification: March 10, 2023

Name(s) of Drug:

See listing below…

Company Name:

Stratford Care USA

Drug Indication:

Supplementation

Product Description

The supplements were packaged in white bottles with various styles of labels affixed. The bottom of the container was marked with lot numbers and expiration dates.

Reason for Recall

At this time, one report has been made of a dog experiencing symptoms of a Vitamin A overdose.

Impacts

Pets who are experiencing a Vitamin A overdose, may experience symptoms of general unwell feelings, nausea, refusal to eat, weakness, tremors, peeling skin, convulsions, paralysis and death.

Lot information

Recalled lots:

Lot 31133, Expiration Date 04/13/2023

Lot 30837, Expiration Date 10/26/2022

Because this supplement was sold under various brand names, it is important to reference the chart below to determine if your pet’s supplement may be included:

Brand Name Product Name UPC (If Applicable)
Orlando Vets Omega-V3 Softgels NA
All Creatures Animal Hospital Omega-V3 Softgels NA
All Veterinary Supply, INC Omega-V3 Softgels NA
Jungle Pet Skin+Coat Omega-3 Soft Gels 85000395223
Animal Medical Clinic Omega V3 Softgels 169682510808
Animal Medical Clinic Melbourne Beach Omega V3 Softgels  
Animal Care Hospital Omega-3 Fatty Acid Max Strength Soft Gels NA
Animal Medical Center Omega-V3 Softgels NA
Barnes Animal Hospital Omega-V3 Softgels NA
Brentwood Animal Hospital Omega-V3 Softgels NA
Cherokee Trail Veterinary Hospital Omega-V3 Softgels NA
Clinton Animal Hospital Omega-V3 Softgels NA
Clyde’s Animal Clinic Omega-V3 Softgels NA
Coastal Animal Clinic Omega-V3 Softgels NA
Columbia Hospital For Animals Omega-V3 Softgels NA
Compassion Veterinary Clinic Omega-V3 Softgels NA
Doc Ladue’s Omega-V3 Softgels NA
Dogwood Veterinary Hospital Omega-V3 Softgels NA
Doral Centre Animal Hospital Omega-V3 Softgels NA
Eagles Landing Veterinary Hospital Omega-V3 Softgels NA
Pet Health Solutions Omega Caps 814087005489
SPCA of North Brevard Omega-V3 Soft Gels  
LaVale Veterinary Hospital Omega-V3 Soft Gels NA
Twin Maples Omega-V3 Soft Gels NA
University Animal Hospital Omega-V3 Soft Gels NA
Venice Pines Veterinary Clinic Omega-V3 Soft Gels NA
Lake Dow Animal Hospital Omega-V3 Soft Gels NA
MVH Mann Veterinary Hospital Omega-V3 Soft Gels NA
All Paws Animal Clinic Royal Palm Beach Omega-V3 Soft Gels NA
Bottle Tree Animal Hospital Omega-V3 Soft Gels NA
Brookwood Veterinary Clinic Omega-V3 Soft Gels NA
Cleveland Park Animal Hospital Omega-V3 Soft Gels NA
Crown Heights Animal Hospital Omega-V3 Softgels NA
Eagle’s Landing Veterinary Hospital Omega-V3 Softgels NA
LVH Veterinary Omega-V3 Softgels NA
Mt Orab Veterinary Clinic Dr. Hayes’s Omega-V3 Soft Gels NA
Oak Tree Animal Hospital Omega-V3 Softgels NA
Patterson Veterinary Hospital – Mason Omega-V3 Softgels NA
Prospect Heights Animal Hospital Omega-V3 Softgels NA
Smyth County Animal Hospital Omega-V3 Softgels NA
Stateline Animal Clinic Omega-V3 Softgels NA
The Pet Clinic of Urbana, LLC Omega-V3 Softgel NA
Valdosta Animal Hospital Omega-V3 Softgels NA
Viking Community Animal Hospital Omega-V3 Softgels NA
Westbrook Animal Hospital Omega-V3 Softgels NA
My Pet Hospital Omega-3 Soft Gels NA
North Shore Animal League America Omega-V3 Softgels NA
NPC Northgate Pet Clinic Omega-V3 Softgels NA
Northwest Tennessee Veterinary Services Omega-V3 Softgels NA
Pawstruck.com Omega-V3 Soft Gels 850005963080
Perry Animal Clinic Omega-V3 Softgels NA
Pleasant Plains Animal Hospital Omega-V3 Softgels NA
Seiler Animal Hospital Omega-V3 Softgels NA
Stratford Animal Health Omega-V3 Softgels NA
Summerfields Animal Hospital Omega-V3 Softgels NA
SensoVet Animal Health Wellness Advanced Omega-3 Softgel NA
University Animal Hospital Omega-V3 Softgels\ NA
Vet4Bulldog V4B Bully Fish oil omega-3 EFA 603981565911
Waggin’ Wheel Vet Clinic Omega-V3 Softgels NA
Wellsboro Small Animal Hospital Veterinary Medical Center Omega-V3 Softgels NA
Wickham Road Animal Hospital Omega-V3 Softgels NA
Wilton Manors Animal Hospital Omega-V3 Softgels NA

www.fda.gov

 Have you found that your pet’s supplement is part of the recall? Here’s what you should do:

Consumers

  1. Stop administering the supplement to your pet right away.
  2. Notify your pet’s veterinarian. Monitor your pet’s health over the next week and notify the veterinarian of any change in their behavior or health.
  3. Consumers may contact Stratford Care, USA at 1-877-498-2002. They are available Mon-Fri from 9:00am to 5:00pm (EST). You can also notify them via email at Adverseevents@stratfordrx.com if your pet has experienced any symptoms related to using the supplement. If you purchased the medication directly from Stratford Care, USA, refund requests can be sent to refunds@stratfordrx.com.
  4. If your pet is currently experiencing or has experienced an adverse reaction to this supplement, notify your veterinarian immediately and report it to the FDA by calling 1-800-332-1088 or completing an online reporting form.
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Retailer

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Retailers may contact Stratford Care, USA at 1-877-498-2002. They are available Mon-Fri from 9:00am to 5:00pm (EST). You can also notify them via email at Adverseevents@stratfordrx.com. Notify them of any recalled batches that have already been sold to consumers.
  3. Notify affected consumers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Wholesaler

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Wholesalers may contact Stratford Care, USA at 1-877-498-2002. They are available Mon-Fri from 9:00am to 5:00pm (EST). You can also notify them via email at Adverseevents@stratfordrx.com. Notify them of any recalled batches that have already been shipped to retailers.
  3. Notify affected retailers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

 

 

Nationwide Recall of Drug Claiming to Cure or Prevent Covid-19

Natural Solutions Foundation has issued a voluntary recall of their product, Dr. Rima Recommends, The Silver Solution after the U.S. Department of Justice filed a civil complaint in the New Jersey District Court due to the company making unsubstantiated claims that the product could prevent or even cure Covid-19. The drug was not approved by the FDA and has not been proven to be an effective treatment for Covid-19. At the time of the writing of this notice, no adverse effects have been reported by consumers, but there are concerns that patients may not seek necessary and life-saving treatment for the illness if they believe that this product is sufficient.

SUMMARY

Date of Recall:

Announced: March 7, 2023

Public Notification: March 8, 2023

Name(s) of Drug:

Dr. Rima Recommends

Dr. Rima Recommends, Nano Silver 10ppm Dietary Supplement

Dr. Rima Recommends, The Silver Solution

Company Name:

Natural Solutions Foundation

Drug Indication:

Prevention/Treatment of Covid-19 and other illnesses.

Product Description

The product is distributed in 16oz bottles labeled as, “Dr. Rima Recommends.”

Reason for Recall

At this time, Natural Solutions Foundations has provided no proof of their claims that the drug can prevent or even cure Covid-19. The drug is not approved for use by the FDA. No adverse effects have been reported at this time, but there are concerns that consumers may not receive necessary or life-saving treatments for their Covid-19 infection if they believe the product is sufficient treatment.

Impacts

Consumers should discontinue use of the product immediately and if they believe that they may have a Covid-19 infection, should notify their physician immediately and seek an approved treatment.

Lot information

All lots are being recalled at this time. They were sold to the public between January 22, 2020 and December 27, 2021.

Have you found that your medication is part of the recall? Here’s what you should do:

Consumers

If you find that you have a bottle of the product that is part of this recall, do the following:

  1. Call your doctor right away if you are experiencing any symptoms of Covid-19, including shortness of breath, cough or loss of taste/smell.
  2. Discontinue use of the product.
  3. Consumers may request a refund by returning any unused portion of the drug to the foundation by mailing it to Natural Solutions Foundation c/o Ralph Fucetola, 58 Plotts Road, Newton, NJ 07860. Include your return mailing address and name and a refund check will be processed and mailed out to you within 14 days of product receipt.
  4. Any additional questions concerning the medication or recall can be emailed to the foundation at admin@inhere.org .
  5. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
  6. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Retailer

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Request a refund by returning any unused portion of the drug to the foundation by mailing it to Natural Solutions Foundation c/o Ralph Fucetola, 58 Plotts Road, Newton, NJ 07860. Include a return mailing address and name and a refund check will be processed and mailed out within 14 days of product receipt.
  3. Contact the foundation with any further questions at admin@inhere.org .
  4. Notify affected consumers of recalled batches that they have already or will receive.
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

 

Wholesaler

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Request a refund by returning any unused portion of the drug to the foundation by mailing it to Natural Solutions Foundation c/o Ralph Fucetola, 58 Plotts Road, Newton, NJ 07860. Include a return mailing address and name and a refund check will be processed and mailed out within 14 days of product receipt.
  3. Notify affected retailers of recalled batches that they have already or will receive.
  4. Contact the foundation with any further questions at admin@inhere.org .
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

 

 

Men’s Erectile Enhancement Capsules Recalled! Dangerous Interactions Possible!

PrimeZEN Black 6000 male enhancement capsules are being recalled after they have been found to be tainted with Sildenafil and Tadalafil. These contaminants can cause dangerous interactions with prescriptions drugs and can lead to a life-threatening hypotension (low blood pressure). Continue reading Men’s Erectile Enhancement Capsules Recalled! Dangerous Interactions Possible!

2nd Nationwide Recall of At-Home, Rapid Covid-19 Test Kits

Skippack Medical Lab has issued an immediate recall of their SARS-CoV-2 (i.e. Coronavirus, Covid-19) Antigen Rapid Test Kits due to a lack of appropriate approval and clearance by the FDA which could result in inaccurate test results. All testing products must be pre-approved by the FDA prior to distribution to the public. In fact, this same test kit was recalled in March of 2022 under the same violation.

SUMMARY

Date of Recall:

Announced: February 9, 2023

Public Notification: February 10, 2023

Name(s) of Drug:

Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test Kit

Company Name:

Skippack Medical Lab

Distributed by: Universal Meditech Inc.

Drug Indication:

At home testing for Covid-19/Coronavirus.

 

Product Description

The tests were sold online and came with varying label styles. Some were distributed in purple and white boxes labeled with “Skippack Medical Lab.” Another variation was sold in blue and white boxes and labeled with “DiagnosUS.” A third variation was distributed in a plain white box without labeling.

Reason for Recall

No reports of injury have been noted at this time, but without prior approval by the FDA the testing kits are unable to be confirmed as accurate and reliable.

Impacts

Consumers utilizing the unapproved testing kits may receive incorrect results leading them to either believe they have Covid-19 when they do not, or leading to the spread of Covid-19 when they receive a faulty negative response. Other possible side-effects are still unknown at this time.

Lot information

This particular recall refers to all 56,300 tests from the company that were manufactured between October 2021 and December 2021 and were distributed in January of 2022.

 

Have you found that your test is part of the recall? Here’s what you should do:

Consumers

If you find that your tests are part of this recall, do the following:

  1. Do not use the tests.
  2. If you have already utilized the tests and are experiencing any symptoms of Covid-19, obtain a new test from your physician or pharmacy and re-test.
  3. Consumers who have not been contacted by the company can contact the company’s legal attorney at 1-702-871-9888. They are available Mon-Fri from 9:00am to 5:00pm (PST). You may also contact them via email at m@linlawgroup.com.
  4. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
  5. Contact MedWaste Management for information and/or assistance with disposing of all testing materials.

 

Retailer

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Retailers who have not been contacted by the company can contact the company’s legal attorney at 1-702-871-9888. They are available Mon-Fri from 9:00am to 5:00pm (PST). You may also contact them via email at m@linlawgroup.com.
  3. Notify affected consumers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled testing materials.

 

Wholesaler

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Wholesalers who have not been contacted by the company can contact the company’s legal attorney at 1-702-871-9888. They are available Mon-Fri from 9:00am to 5:00pm (PST). You can also contact them via email at m@linlawgroup.com.
  3. Notify affected retailers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled testing materials.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

 

 

Nationwide Recall Over-the-Counter Artificial Tears Lubricant Eye Drops

Global Pharma Healthcare has issued an immediate recall of all lots of their Artificial Tears Lubricant Eye Drops within all current expiration periods. The drops have been found to contain a contaminant. As of the writing of this notice, 55 people have reported adverse effects related to these drops, including complete loss of vision, eye infections and even death.

SUMMARY

Date of Recall:

Announced: February 2, 2023

Public Notification: February 2, 2023

Name(s) of Drug:

EzriCare, LLC Artificial Tears Lubricant Eye Drops

Delsam Pharma Artificial Tears Lubricant Eye Drops

Company Name:

Global Pharma Healthcare

Drug Indication:

Dry Eyes

Irritated Eyes

Product Description

The eye drops are packaged in 15mL bottles that are distributed in individual boxes. Each bottle and box are labeled clearly with the name of the product and the dosage (10mg in 1mL).

Reason for Recall

55 people have reported infections, permanent loss of vision and even death after using the product. It is believed that a contaminate in the drops is causing the infection.

Impacts

Consumers who have used the eye drops should discontinue it’s use immediately and notify your medical provider. Monitor your overall health closely in coming weeks and notify your physician of any health related changes or concerns, particularly in relation to your eyes and vision.

Lot information

ALL lots within their current expiration period are being recalled. Any expired medication should always be disposed of properly.

Have you found that your medication is part of the recall? Here’s what you should do:

 Consumers

If you find that your lot of medication is part of this recall, do the following:

  1. Call your doctor right away. Notify them of your use of a recalled medication and report any changes in your vision or concerning symptoms related to your eyes or overall health.
  2. Continue to monitor your health for any adverse symptoms over the next few weeks and notify your physician if any concerns are noted.
  3. Consumers should contact Aru Pharma/Ezricare, LLC at 1-516-715-5181. They are available Mon-Fri from 11:00am to 4:00pm (EST). You can also contact them via email at arupharmainc@yahoo.com. DELSAM Pharma, LLC can be reached at 1-866-826-1306. They are available 11:00am to 4:00pm (EST) and their email is delsampharma@yahoo.com.
  4. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Retailer

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact Aru Pharma/Ezricare, LLC at 1-516-715-5181. They are available Mon-Fri from 11:00am to 4:00pm (EST). You can also contact them via email at arupharmainc@yahoo.com. DELSAM Pharma, LLC can be reached at 1-866-826-1306. They are available 11:00am to 4:00pm (EST) and their email is delsampharma@yahoo.com.
  3. Notify the manufacturer of any recalled batches that have already been sold to consumers.
  4. If possible, notify affected consumers of recalled batches that they have already or will receive.
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Wholesaler

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact Aru Pharma/Ezricare, LLC at 1-516-715-5181. They are available Mon-Fri from 11:00am to 4:00pm (EST). You can also contact them via email at arupharmainc@yahoo.com. DELSAM Pharma, LLC can be reached at 1-866-826-1306. They are available 11:00am to 4:00pm (EST) and their email is delsampharma@yahoo.com.
  3. Notify affected retailers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

 

 

Nationwide Recall of TIROSINT®-SOL (levothyroxine sodium) Oral Solution Due to Potency

IBSA Pharma Inc. has issued an immediate recall of a large number of batches of the medication TIROSING®-SOL due to potency issues. The affected lots have been found to be less potent than labeled, putting consumers at risk of decreasing T4 levels and return of their hypothyroid symptoms.

SUMMARY

Date of Recall:

Announced: January 31, 2023

Public Notification: February 1, 2023

Name(s) of Drug:

TIROSINT®-SOL

Levothyroxine Sodium Solution

(CAPSULES NOT AFFECTED. RECALL APPLIES TO SOLUTION ONLY)

Company Name:

IBSA Pharma Inc.

Drug Indication:

Hypothyroidism

Pituitary Thyrotropin Suppression

Thyroid Cancer (adjunct medication)

 

Product Description

TIROSINT®-SOL is a clear, odorless solution that is packaged in individual ampules for oral consumption. Each ampule is individually labeled with the product name and dosage. Each box of ampules is labeled with further information such as the NDS numbers, lot numbers, and expiration dates. This recall effects several different dosages of the medication, therefore all consumers of this product should confirm if their particular lots are listed.

Reason for Recall

The labeled amount of levothyroxine sodium in each ampule has been found to be less than 95% of what is indicated on the label. Particularly for patients who are sensitive to minor changes in their T4 levels, or patients who only take the medication on a weekly or bi-weekly basis, this variation in potency could lead to serious side effects.

Impacts

Consumers who have received an effected batch of the medication and who continue to utilize it may experience symptoms related to decreased T4 such as fatigue, increased sensitivity to cold, constipation, dry skin, slow heart rate, depression, swelling of the thyroid gland, puffy face, and/or hair loss.

Lot information

Consumers should locate the box in which the medication comes to compare NDC and lot numbers as well as expiration dates with the chart below. If you find your NDC number, lot number and expiration date on the chart below, your medication is affected by the recall and you will need to take additional steps in order to ensure that your health is not affected and to take part in recall procedures.

Note: Each strength is highlighted in a different color. Your box may have varying coloring, but you will find the NDC, Lot Number and Expiration Date in the same area on each package.

Product Description NDC Lot Number Expiration Date
TIROSINT-SOL 13 mcg/mL 30 units carton-box 71858-0105-5 220409 10/2023
TIROSINT-SOL 13 mcg/mL 30 units carton-box 71858-0105-5 220956 03/2024
TIROSINT-SOL 25 mcg/mL 30 units carton-box 71858-0110-5 220856 02/2024
TIROSINT-SOL 37.5 mcg/mL 30 units carton-box 71858-0112-5 220552 11/2023
TIROSINT-SOL 37.5 mcg/mL 30 units carton-box 71858-0112-5 221055 04/2024
TIROSINT-SOL 44 mcg/mL 30 units carton-box 71858-0113-5 220553 11/2023
TIROSINT-SOL 44 mcg/mL 30 units carton-box 71858-0113-5 221056 04/2024
TIROSINT-SOL 50 mcg/mL 30 units carton-box 71858-0115-5 220407 10/2023
TIROSINT-SOL 50 mcg/mL 30 units carton-box 71858-0115-5 220960 03/2024
TIROSINT-SOL 62.5 mcg/mL 30 units carton-box 71858-0117-5 220556 11/2023
TIROSINT-SOL 62.5 mcg/mL 30 units carton-box 71858-0117-5 221058 04/2024
TIROSINT-SOL 75 mcg/mL 30 units carton-box 71858-0120-5 220853 02/2024
TIROSINT-SOL 88 mcg/mL 30 units carton-box 71858-0125-5 220411 10/2023
TIROSINT-SOL 88 mcg/mL 30 units carton-box 71858-0125-5 220854 02/2024
TIROSINT-SOL 100 mcg/mL 30 units carton-box 71858-0130-5 220413 10/2023
TIROSINT-SOL 100 mcg/mL 30 units carton-box 71858-0130-5 220964 03/2024
TIROSINT-SOL 112 mcg/mL 30 units carton-box 71858-0135-5 220414 10/2023
TIROSINT-SOL 112 mcg/mL 30 units carton-box 71858-0135-5 220852 02/2024
TIROSINT-SOL 112 mcg/mL 30 units carton-box 71858-0135-5 220970 03/2024
TIROSINT-SOL 125 mcg/mL 30 units carton-box 71858-0140-5 220855 02/2024
TIROSINT-SOL 137 mcg/mL 30 units carton-box 71858-0145-5 220415 10/2023
TIROSINT-SOL 137 mcg/mL 30 units carton-box 71858-0145-5 221052 04/2024
TIROSINT-SOL 150 mcg/mL 30 units carton-box 71858-0150-5 220959 03/2024
TIROSINT-SOL 175 mcg/mL 30 units carton-box 71858-0155-5 220416 10/2023
TIROSINT-SOL 175 mcg/mL 30 units carton-box 71858-0155-5 221053 04/2024
TIROSINT-SOL 200 mcg/mL 30 units carton-box 71858-0160-5 220418 10/2023
TIROSINT-SOL 200 mcg/mL 30 units carton-box 71858-0160-5 220560 11/2023

FDA.gov

Have you found that your medication is part of the recall? Here’s what you should do:

Consumers

NOTE: CONSUMERS SHOULD NOT DISCONTINUE THIS MEDICATION ABRUPTLY. SPEAK TO YOUR DOCTOR BEFORE MAKING ANY CHANGES.

Discontinuation of this medication may cause symptoms of hypothyroidism to return in a prompt and sometimes serious way. These may include:

  • Bradycardia (slowed heart rate)
  • Depression
  • Fatigue
  • Constipation
  • Muscle weakness
  • Irregular or heavy menstrual cycles
  • Weight gain
  • Difficulty tolerating cold
  • Memory deficits
  • Puffy face
  • Dry skin
  • Thinning hair

If you find that your lot of medication is part of this recall, do the following:

  1. Call your doctor right away. Ask for a new prescription to replace your recalled medication and report any changes in your symptoms.
  2. Continue to monitor your health for any adverse symptoms over the next week and notify your physician if any concerns are noted.
  3. Consumers should contact IBSA Pharma Inc. at 1-800-587-3513. They are available Mon-Fri from 9:00am to 7:00pm (EST). You can also contact them via email at medinfo@ibsapharma.com.
  4. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
  5. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Retailer

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact IBSA Pharma Inc at 1-855-224-0231 or you can utilize IBSACS@Eversana.com to contact them via email. Notify them of any recalled batches that have already been sold to consumers.
  3. Notify affected consumers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Wholesaler

  1. Examine all inventory and remove stock that is affected by the recall immediately.
  2. Contact IBSA Pharma Inc at 1-855-224-0231 or you can utilize IBSACS@Eversana.com to contact them via email. Notify them of any recalled batches that have already been shipped to retailers.
  3. Notify affected retailers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

Mylan Pharmaceuticals initiates voluntary recall of one lot of Alprazolam

Mylan Pharmaceuticals initiates voluntary nationwide recall of one lot of Alprazolam tablets, USP C-IV 0.5 mg, due to the potential of foreign substance.

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Drugs
Reason for Announcement:
Potential presence of foreign substance
Company Name:
Mylan Pharmaceuticals Inc.
Brand Name:
Mylan Pharmaceuticals Inc.
Product Description:
Alprazolam Tablets, USP C-IV 0.5 mg

Company Announcement

Mylan Pharmaceuticals Inc. is conducting a voluntary nationwide recall of one lot (see table below) of Alprazolam Tablets, USP C-IV 0.5 mg, to the consumer/user level. This lot is being recalled due to the potential presence of foreign substance. Clinical impact from the foreign material, if present, is expected to be rare, but the remote risk of infection to a patient cannot be ruled out. To date, Mylan has not received any adverse events related to this batch.

Alprazolam Tablets are indicated for the management of anxiety disorder, the short-term relief of symptoms of anxiety, and the treatment of panic disorder, with or without agoraphobia.

Alprazolam Tablets, USP C-IV 0.5 mg, are packaged in bottles of 500. This batch was distributed in the U.S. between July 2019 and August 2019. The recalled lot is as follows:

NDC

Product Description and Strength

Size

Lot number

Expiry

0378-4003-05 Alprazolam Tablets, USP C-IV 0.5 mg Bottles of 500 8082708 September 2020

Mylan has notified its distributors and customers by letter and is arranging for return of all recalled products. Following are actions for wholesalers, retailers and consumers:

  • Wholesaler: Immediately examine your inventory, quarantine and discontinue distribution of these lots. In addition, if you have further distributed the product, please identify your retail level customers and provide a list of customers via Microsoft excel file to mylan5924@stericycle.com within 10 business days. Stericycle will notify your retail level customers that received the affected batches.
  • Retailer: Immediately examine your inventory, quarantine and discontinue distribution of these lots. Additionally, if you have further distributed the product, please identify the consumer and notify them immediately of this product recall. The consumer should be instructed to contact Stericycle at 1-888-843-0255 for the documentation packet to return the product.
  • Consumer: Please contact Stericycle at 1-888-843-0255 for the documentation packet to return product to Stericycle.

Consumers with questions can contact Mylan Customer Relations at 800.796.9526 or customer.service@mylan.com, Monday through Friday from 8 a.m. – 5 p.m. EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration

 

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Learn How To Properly Manage & Dispose of Household Medical Waste

Dried pig ear treat with a recall announcement

Voluntary Recall: Pig Ear Pet Treats; No Illnesses Reported; Strictly Precautionary

TDBBS LLC Voluntary Recalls: Pig Ear Pet Treats; No Illnesses Reported; Strictly Precautionary.

This product was shipped to customers between April 22, 2019, and August 13, 2019.  Customers should dispose of any USA Thick Pig Ear 8 Pack and USA Thick Pig Ear 20 Pack from these shipments.

This recall is the result of routine sampling conducted by the Michigan Department of Agriculture & Rural Development. The sample bag tested positive for SalmonellaSalmonella can affect animals eating the products, and there is risk to humans from handling contaminated pet products, especially if they have not thoroughly washed their hands after having contact with the products or surfaces exposed to these products.

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Animal & Veterinary
Animal Feed
Reason for Announcement:
Salmonella contamination
Company Name:
TDBBS LLC
Brand Name:
TDBBS
Product Description:
Pig ear pet treat

TDBBS Company Contact Information

Consumers:
 877-483-5853
 customerservice@tdbbsllc.com

Company Announcement

Below is a company statement from TDBBS regarding a limited voluntary recall:

“As a strictly precautionary measure and because of our company’s strong commitment to the health and well-being of pets, TDBBS is conducting a voluntary recall of a limited distribution of two pig ear pet treat products sold through Amazon.com – USA Thick Pig Ear 8 Pack and USA Thick Pig Ear 20 Pack.

“This recall has been initiated due to possible Salmonella contamination, which poses a health risk. It is important to know that no illnesses have been reported, and the amount of affected product is minimal.

“TDBBS treats and chews are produced to robust safety and quality standards, using the most advanced food safety protocols. Our team is committed to doing its part to caring for the pets who enjoy our products. We regret the concern and inconvenience this recall creates for our customers.

“Our company has ceased the production and distribution of this product as we, in cooperation with the FDA, continue to investigate the situation further. TDBBS’s product safety team is conducting its own stringent review to identify what measures can be established to prevent this situation from recurring.

“Our safety teams have been rigorously testing our products and raw materials, working with independent testing firms and conducting an internal investigation within our supply chain to determine how this situation occurred. Nevertheless, we believe it is appropriate out of an abundance of caution to conduct this voluntary recall in cooperation with our customer.”

TDBBS provided the following information about specific products recalled:

TDBBS, LLC USA Thick Pig Ear 8 Pack TDBBS, LLC USA Thick Pig Ear 20 Pack
UPC: X001768PNB UPC: X000RBC5VF
Best By Date: 4/22/2021 Lot Code: 1129T1 Best By Date: 4/22/2021 Lot Code: 1129T1
Best By Date: 6/06/2021 Lot Code: 1549T1 Best By Date: 5/13/2021 Lot Code: 1339T1
Best By Date: 8/05/2021 Lot Code: 2179T1

Healthy people infected with Salmonella should monitor themselves for some or all the following symptoms: nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramping and fever. Rarely, Salmonella can result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms. Consumers exhibiting these signs after having contact with this product or a pet that has eaten the product should contact their healthcare providers.

Pets with Salmonella infections may be lethargic and have diarrhea or bloody diarrhea, fever, and vomiting. Some pets will have only decreased appetite, fever and abdominal pain. Infected but otherwise healthy pets can be carriers and infect other animals or humans. If your pet has consumed the recalled product and has these symptoms, please contact your veterinarian.

All UPCs, Best By Dates and Lot Codes are located on the package back. Pictures of product labels are below.

Consumers may contact customer service at 877-483-5853, Monday to Friday 9-5pm or email TDBBS at customerservice@tdbbsllc.com.

 

Product Photos

Example Product label – 20 pack

Product photo – pig ear

Example Product label – 20 pack

A banner that reads: Click here to manage household sharps and medicine waste. And get a free sharps container!
Household medical waste disposal

PRE-TAT Cream is Being Recalled Due to Risk of Infection

Ridge Properties, LLC, issued a recall of 4% lidocaine topical cream & liquid gel products like PRE-TAT and SUPERIOR Pain and Itch Relief, sold at the consumer level.

The products are being recalled due to Microbiological Contamination and Superpotency.

These products are used as a topical anesthetic and are packaged in black jars or bottles with metallic red or green lettering.

Products were distributed nationwide through online sales at the following websites: amazon.com, ebay.com, walmart.com, tatbalm.net, & naturallyhl.com.

The products being recalled include:

PRE-TAT– a numbing agent/topical anesthetic used before applying the tattoo.

The risk from using a contaminated product on skin before a tattoo are greater than normal since the skin is traumatized right after application.

Also, the tattooing process itself can have infectious complications. Introducing more microbiological contamination really increases the risk for getting those complications along with the tattoo.

Soothing Sore Relief Cream– marketed for soothing pain and/or itching associated with hemorrhoids and bedsores.

Superior Pain and Itch Relief– marketed as a numbing agent and topical anesthetic.

The potency of lidocaine in these products is higher than the amount written on the label.

The problem with using a greater potency of lidocaine is the increased risk of methemoglobinemia, a blood disorder that involves the production of abnormal amounts of methemoglobin.

The FDA website has a full list of the recalled products, with their lot numbers and expiration dates.

To date, the company has not received any reports of adverse events related to this recall.
No products from the contaminated lots are currently for sale, or in stock at company or any of its distributors.

The company is notifying its customers by press release and recall letter, and is arranging for replacement of all recalled products.

If you have one of the products with the specified lot number, stop using the product and discard it.

You can also return the product and use the recall response form to reach out to the company for a replacement. Email the form to prncustomercare@gmail.com, or use snail mail to send it to the following address:

Pain Relief Naturally Recall Department
4995 Ridge Dr NE
Salem, OR, 97301

Forms will be sent to you if you have bought this product recently.

If you have questions regarding this recall, contact the company by phone at 877-906-4806, 9 am – 5 pm Monday-Friday, pacific time, or by email at prncustomercare@gmail.com.

If you used the recalled product, and have experienced problems, talk to your healthcare provider. Adverse reactions or quality problems experienced with the use of this product can also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

_____________

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California

 

This Product Has Been Recalled 75 Times

On May 6, 2019, Vivimed Life Sciences put out another recall for losartan.

The American Health Packaging recall of valsartan on March 7, 2019, the 75th recall of blood pressure medication since the initial contamination occurred.

The problem with the contamination of blood pressure medication has gotten so widespread that the FDA authorized a new generic of valsartan to help relieve shortages when lots after lots of the existing medication were recalled.

Also, the agency compiled a list of 40 blood pressure medications that seem free of contamination. You can find that list here.

Which blood pressure drugs have been recalled?

The common prescription drugs for blood pressure that have been recalled so far include valsartan, losartan, and irbesartan in different combinations and from different manufacturers.

Why have the drugs been recalled?

In each case, a recalled drug was contaminated with N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA) or N-Nitroso N-Methyl 4-amino butyric acid (NMBA).

Those chemicals are believed to cause cancer in humans. Research also suggests NDEA can cause liver and blood cell damage.

NDEA is a byproduct of industrial processes, and the FDA is working on identifying how it has been getting into the medication. It can also be created by other chemical reactions. It is found in very low levels in some food and in drinking water, and is used to make rocket fuel.

Can you get cancer from the contaminated drugs?

The FDA says the risk is very low. They estimate that if 8,000 people took the highest valsartan dose, which is 320 milligrams, from recalled batches every day for 4 years, there would likely only be one additional case of cancer over the life of those 8,000 people.

What should you do if you have a perscription for one of the recalled drugs?

Don’t stop taking the medication. The threat from the contamination in the drug is a lesser threat than the consequences of stopping the use of the medication.

However, do contact your pharmacist or Doctor as soon as possible.

They can help you find an alternative.

Because so much of the blood pressure drugs have been recalled, this may be a little more difficult than usual. Also, keep in mind that drugs that are not on the list of recalls are more in demand and therefore the price may have gotten higher.

WebMD has an article up that summarizes the rash of blood pressure medication recalls. You can read the full report here.

_____

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management brings great benefit to the healthcare industry and the general public alike. We publish this blog to to spread useful and practical information to help people stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to speak!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store 

Home Generated Medical Waste Drop-Off Points In California